Neoprospecta Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 43
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $1.78M
Latest Deal Amount
  • Investors
  • 2

Neoprospecta General Information

Description

Developer of a platform designed to deal with microbiological analysis, management, and control. The company's technologies are dedicated to the development and commercialization of innovative microbiological analyzes, based on new generation DNA sequencing, biocomputational analysis and quantitative PCR techniques which has created a line of rapid tests for the detection of microorganisms and antibiotic resistance genes, enabling to provide in the areas of contamination and outbreak tracking and control, food safety and good practices for microbiological control, helping companies in decision making from microbiome information.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Av. Luiz Boiteux Piazza, 1302 - InovaLab
  • Bom Jesus, Waterfall Sapiens Park
  • Florianópolis, 88056
  • Brazil
+55 (48) 0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neoprospecta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 08-Aug-2014 $1.78M 00.000 Completed Startup
1. Early Stage VC 15-Feb-2013 00000 00000 Completed Startup
To view Neoprospecta’s complete valuation and funding history, request access »

Neoprospecta Executive Team (3)

Name Title Board Seat Contact Info
Luiz Fernando Valter de Oliveira Co-Founder & Chief Executive Officer
Luiz Felipe Valter de Oliveira Ph.D Co-Founder & Board Member
To view Neoprospecta’s complete executive team members history, request access »

Neoprospecta Board Members (1)

Name Representing Role Since
Luiz Felipe Valter de Oliveira Ph.D Neoprospecta Co-Founder & Board Member 000 0000
To view Neoprospecta’s complete board members history, request access »

Neoprospecta Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neoprospecta Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CVentures Venture Capital Minority 000 0000 000000 0
IDEE (Other Commercial Products) Venture Capital Minority 000 0000 000000 0
To view Neoprospecta’s complete investors history, request access »